SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BOREA, Pier Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 45.311
AS - Asia 22.894
EU - Europa 16.372
SA - Sud America 3.594
AF - Africa 338
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 30
Totale 88.573
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 44.511
SG - Singapore 8.771
CN - Cina 7.019
DE - Germania 3.623
IT - Italia 3.256
UA - Ucraina 3.067
BR - Brasile 3.021
TR - Turchia 2.297
HK - Hong Kong 2.183
GB - Regno Unito 1.614
VN - Vietnam 1.340
SE - Svezia 1.141
FI - Finlandia 1.024
RU - Federazione Russa 882
FR - Francia 462
PL - Polonia 431
MX - Messico 367
CA - Canada 358
IN - India 252
AR - Argentina 235
NL - Olanda 227
ID - Indonesia 179
ZA - Sudafrica 176
BD - Bangladesh 174
JP - Giappone 158
BE - Belgio 138
ES - Italia 125
EC - Ecuador 94
IQ - Iraq 91
LT - Lituania 81
CZ - Repubblica Ceca 77
AT - Austria 63
CL - Cile 54
CO - Colombia 53
VE - Venezuela 52
PK - Pakistan 46
UZ - Uzbekistan 46
PY - Paraguay 41
AE - Emirati Arabi Uniti 40
IR - Iran 40
MA - Marocco 37
SA - Arabia Saudita 31
AU - Australia 27
JO - Giordania 27
IL - Israele 26
KE - Kenya 26
TN - Tunisia 26
KR - Corea 24
IE - Irlanda 23
EU - Europa 21
UY - Uruguay 20
EG - Egitto 19
RO - Romania 19
DZ - Algeria 16
PT - Portogallo 15
NP - Nepal 14
BG - Bulgaria 13
KZ - Kazakistan 13
PE - Perù 13
TW - Taiwan 13
AL - Albania 11
MY - Malesia 11
PS - Palestinian Territory 11
AZ - Azerbaigian 10
CH - Svizzera 10
DO - Repubblica Dominicana 10
HN - Honduras 10
SN - Senegal 10
NO - Norvegia 9
PA - Panama 9
BH - Bahrain 8
CR - Costa Rica 8
JM - Giamaica 8
LV - Lettonia 8
OM - Oman 8
PH - Filippine 8
LB - Libano 7
SY - Repubblica araba siriana 7
AM - Armenia 6
BO - Bolivia 6
MD - Moldavia 6
TT - Trinidad e Tobago 6
XK - ???statistics.table.value.countryCode.XK??? 6
BA - Bosnia-Erzegovina 5
BN - Brunei Darussalam 5
BY - Bielorussia 5
CG - Congo 5
CI - Costa d'Avorio 5
ET - Etiopia 5
GR - Grecia 5
GT - Guatemala 5
HR - Croazia 5
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
RS - Serbia 5
GA - Gabon 4
GE - Georgia 4
GY - Guiana 4
HU - Ungheria 4
MK - Macedonia 4
Totale 88.505
Salva come PNG Salva come JPEG
Città #
Singapore 5.283
Woodbridge 4.579
Ashburn 3.967
Fairfield 3.673
Jacksonville 3.295
Chandler 2.909
Houston 2.876
Ann Arbor 2.405
Hong Kong 2.174
Santa Clara 2.084
Beijing 2.036
Wilmington 1.658
Seattle 1.546
Dallas 1.483
Cambridge 1.157
Izmir 1.121
Nanjing 1.018
Los Angeles 723
Princeton 711
Munich 527
Boardman 526
Ho Chi Minh City 469
Ferrara 452
New York 429
Milan 423
Warsaw 374
San Diego 345
Nanchang 323
Shanghai 310
Shenyang 306
Falkenstein 290
São Paulo 274
Hanoi 270
Mexico City 243
Hefei 242
Tianjin 218
Hebei 204
Dearborn 203
Helsinki 198
Turku 194
Changsha 187
London 183
Bremen 182
San Mateo 176
Addison 170
Jiaxing 169
Chicago 150
The Dalles 147
Tokyo 143
Council Bluffs 140
Brussels 134
Buffalo 131
Frankfurt am Main 129
Brooklyn 127
Jinan 126
Orem 120
Falls Church 115
Montreal 113
Zhengzhou 110
Jakarta 109
San Jose 107
Rome 100
Kunming 99
Johannesburg 96
Moscow 96
Auburn Hills 94
Denver 94
Norwalk 94
Rio de Janeiro 93
San Francisco 92
Toronto 91
Stockholm 86
Mountain View 85
Amsterdam 84
Chennai 83
Guangzhou 82
Ningbo 80
Phoenix 80
Atlanta 76
Philadelphia 75
Poplar 75
Boston 73
Bologna 69
Manchester 68
Florence 66
Belo Horizonte 65
Düsseldorf 63
Orange 63
Redwood City 63
Da Nang 62
Haiphong 60
Ankara 58
Verona 57
Des Moines 53
Augusta 51
Brasília 49
Dong Ket 46
Mumbai 45
Washington 45
Curitiba 43
Totale 57.340
Salva come PNG Salva come JPEG
Nome #
Farmacologia cellulare e molecolare, sistemi di trasmissione e autacoidi. Trasmissione purinergica 1.311
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 1.175
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 349
Progetto ex 60%- I recettori dell’adenosina come possibili “biomarkers” dei tumori colorettali. Studio su tessuti umani sani e tumorali e sulle cellule del sangue periferico. 348
Pharmacology of Adenosine Receptors: The State of the Art 300
A glance at adenosine receptors: Novel target for antitumor therapy 268
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 267
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 262
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 257
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 242
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 242
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 239
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 239
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 235
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 232
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 228
Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts 224
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 224
7-Chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine (medazepam) 222
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 221
The A3 adenosine receptor: history and perspectives 219
Adenosine receptors and human melanoma 218
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 218
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 216
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 216
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 216
Recettori e trasduzione del segnale 215
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 215
Recettori e trasduzione del segnale 214
6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors 214
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 213
2 Aralkynyl and 2-heteroalkynyl derivatives of adenosine 5'-N-ethyluronamide as selective A2A adenosine receptor agonists 212
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 211
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 210
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 207
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 206
Adenosine receptor targeting in health and disease 206
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 204
Adenosine A1 receptors in the rat brain in the kindling model of epilepsy 203
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 202
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 201
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 201
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 201
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. 200
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 199
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 198
Comparison of prazosin, terazosin and tamsulosin: Functional and binding studies in isolated prostatic and vascular human tissues 198
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents 198
Octadecyl, phenyl and cyano phases comparison for the RP-HPLC prediction of octanol-water partition coefficient 197
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 197
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 197
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 197
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 194
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 194
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 194
Adenosine signaling contributes to ethanol-induced fatty liver in mice 193
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 193
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2 192
Ala scan analogues of HOE 140. Synthesis and biological activities 191
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 191
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 190
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 189
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 189
Current status of A1 adenosine receptor allosteric enhancers 189
Adenosine receptors and cancer 188
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension 187
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 187
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 187
7-nitro-1,3-dihydro-5-phenyl-1,4-benzodiazepin-2-one (nitrazepam) 187
van't Hoff Based Thermodynamics 186
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 185
P2X1 and P2X3 Purinergic Receptors Differentially Modulate the Inflammatory Response in Human Osteoarthritic Synovial Fibroblasts 185
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 185
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 184
Novel role for polycystin-1 in modulating cell proliferation through calcium oscillations in kidney cells 184
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 184
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 184
Temperature dependence of [3H]PAF binding to washed human platelets 183
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 183
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 183
Receptor binding at two different temperatures to discriminate agonist and antagonist behaviour of adenosine A1 receptor ligands in rat brain 182
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 182
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 182
Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies 182
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 181
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 181
A concerted binding study using binding measurements, X-ray structural data and molecular modeling on the stereochemical features responsible for the affinity of 6-arylpyrrolo[2,1-d][1,5]benzothiazepines to mitochondrial benzodiazepine receptors 181
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 181
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 180
A3 Receptors are Overexpressed in Pleura from Mesothelioma Patients and Reduce Cell Growth via Akt/NF-kB Pathway. 180
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors 179
5-heteroarylcarbamoylamino-pyrazolo-triazolo pyrimidines as hA3 adenosine receptor antagonists. 178
7-substituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: importance of modifications at the side chain on the activity and solubility. 178
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 178
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor 178
Pathological overproduction: the bad side of adenosine 178
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 178
A3 adenosine receptors are overexpressed in pleura from patients with mesothelioma and reduce malignant mesothelioma cell growth 177
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 177
Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts 177
Totale 22.555
Salva come PNG Salva come JPEG
Categoria #
all - tutte 395.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 15.199
Totale 410.339
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.807 0 0 0 0 0 860 233 937 154 1.054 1.109 460
2021/20226.405 141 667 443 343 406 252 229 321 245 500 823 2.035
2022/20236.799 720 418 200 898 1.133 1.042 273 566 876 53 372 248
2023/20243.370 354 442 175 97 353 386 183 242 66 101 107 864
2024/202513.457 395 383 1.062 633 1.646 1.192 406 904 1.847 1.522 1.911 1.556
2025/202622.053 3.833 1.684 3.942 4.949 5.365 2.280 0 0 0 0 0 0
Totale 89.215